申请人:BIOGEN MA INC.
公开号:US10034869B2
公开(公告)日:2018-07-31
The present invention provides compounds of formula (I) or (II) or a pharmaceutically acceptable salt thereof and their use in modulating the activity of S1P receptors. Also provided is a pharmaceutical composition comprising the compounds of formula (I) or (II) or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable excipient or carrier.
本发明提供了式(I)或(II)化合物或其药学上可接受的盐及其在调节 S1P 受体活性中的用途。本发明还提供了一种药物组合物,该组合物包含式(I)或(II)化合物或其药学上可接受的盐以及药学上可接受的赋形剂或载体。